Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors × Lomustine × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 43 Brain Neoplasms 22 Central Nervous System Neoplasms 21 Glioma 14 Astrocytoma 14 Medulloblastoma 8 Oligodendroglioma 7 Recurrence 6 Neoplasms 6 Gliosarcoma 6 Spinal Cord Neoplasms 2 Ependymoma 2 Sarcoma 1 Pancreatic Neoplasms 1 Optic Nerve Glioma 1 Neuroectodermal Tumors 1 Neoplasm Recurrence, Local 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukemia-Lymphoma, Adult T-Cell 1 Kidney Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Familial ependymoma 1 Drug-Related Side Effects and Adverse Reactions 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Cognition Disorders 1

Interventions

Temozolomide 2 vorasidenib 1 pembrolizumab 1 pamiparib 1 cixutumumab 1 Vorinostat 1 Vincristine 1 Valproic Acid 1 Thiotepa 1 Radiotherapy 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Oncolytic Virotherapy 1 ONC206 1 Melphalan 1 Maintenance Chemotherapy 1 Lomustine 1 Interleukin-12 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Erlotinib Hydrochloride 1 Cisplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Antibodies, Monoclonal 1 Aminolevulinic Acid 1 Amifostine 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡